Suppr超能文献

网络药理学和分子对接技术研究二童咳颗粒治疗咳嗽的作用机制。

Study on the mechanism of ErtongKe granules in the treatment of cough using network pharmacology and molecular docking technology.

机构信息

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.

School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China; Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Henan Engineering Laboratory of Traditional Chinese Medicine Clinical Evaluation Technology, Pharmaceutical Department, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China; Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Respiratory Diseases, Henan University of Chinese Medicine, Zhengzhou, China.

出版信息

Ann Palliat Med. 2021 Nov;10(11):11415-11429. doi: 10.21037/apm-21-2807.

Abstract

BACKGROUND

The etiology and pathogenesis of cough are complex. As a Chinese patent medicine that has been on the market, ErtongKe (ETK) granules have a good effect in treating acute and chronic cough in children. The purpose of this research was to determine the bioactive components and possible action mechanisms of ETK in the treatment of cough using an integrated network pharmacology method.

METHODS

The Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Swiss target prediction databases were used to screen the potential components and associated targets of ETK. The Genecards database was then used to gather targets interacting with cough. An analysis of the signaling pathways associated with ETK for cough treatment was carried out using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) enrichment analysis methods. Cytoscape 3.8.1 was used to design the protein-protein interaction (PPI) and compound-target-pathway networks. Finally, the important genes and active components of ETK were confirmed using Auto Dock vina and Discovery studio software.

RESULTS

Total 242 active components of ETK were screened, 1,173 potential targets related to the ingredients and 4,400 targets related to cough were collected separately. Moreover, 600 candidate targets and 39 signaling pathways were determined. We also screened out the following core components, including tuberostemonone, quercetin, kaempferol, praeruptorin E, stigmasterol, oroxylin A, and other potentially active ingredients. At the same time, 8 core targets, including JUN, PIK3CA, PIK3R1, MAPK14, EGFR, SRC, AKT1, and MAPK1, and 20 key pathways, including the cAMP signaling pathway, calcium signaling pathway, and PI3K-Akt signaling pathway among others, were also selected. All the 8 core targets were verified by molecular docking.

CONCLUSIONS

This research established that ETK exerts anti-cough activity by modulating several targets and pathways through multiple components. Additionally, the pooled results shed light on ETK compounds being investigated as potential antitussives.

摘要

背景

咳嗽的病因和发病机制复杂。二丁颗粒作为一种已上市的中药制剂,对治疗小儿急、慢性咳嗽具有良好的疗效。本研究旨在采用整合网络药理学方法,明确二丁颗粒治疗咳嗽的药效物质基础及作用机制。

方法

利用中药系统药理学数据库与分析平台(TCMSP)和瑞士靶点预测数据库筛选二丁颗粒的潜在活性成分及其作用靶点;利用基因综合数据库(Genecards)收集与咳嗽相关的作用靶点;采用京都基因与基因组百科全书(KEGG)数据库和基因本体(GO)数据库对二丁颗粒治疗咳嗽的作用通路进行分析;利用 Cytoscape 3.8.1 软件构建蛋白-蛋白相互作用(PPI)网络和化合物-靶点-通路网络;最后利用 Auto Dock Vina 和 Discovery studio 软件对二丁颗粒的重要基因和活性成分进行验证。

结果

共筛选得到二丁颗粒的 242 个活性成分,分别收集到与成分相关的 1173 个潜在靶点和与咳嗽相关的 4400 个靶点;并确定了 600 个候选靶点和 39 条信号通路。筛选出潜在的核心成分,包括土木香内酯、槲皮素、山奈酚、前胡素 E、豆甾醇、氧化槐定碱等,以及 potentially active ingredients。同时,筛选出 8 个核心靶点,包括 JUN、PIK3CA、PIK3R1、MAPK14、EGFR、SRC、AKT1 和 MAPK1,20 条关键通路,包括 cAMP 信号通路、钙信号通路、PI3K-Akt 信号通路等,所有 8 个核心靶点均通过分子对接进行验证。

结论

本研究表明,二丁颗粒通过多种成分、多个靶点来发挥抗咳嗽作用,为二丁颗粒治疗咳嗽的药效物质基础和作用机制提供了理论依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验